IRVINE, Calif.--(BUSINESS WIRE)--Immunis, Inc., a clinical-stage biotech developing multi-active biologics for age and disease-related immune dysregulation, announces that it has initiated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback